Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Markus Miholits"'
Autor:
Logan R. Van Nynatten, Michael R. Miller, Maitray A. Patel, Mark Daley, Guido Filler, Sigrun Badrnya, Markus Miholits, Brian Webb, Christopher W. McIntyre, Douglas D. Fraser
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-17 (2023)
Abstract Acute and chronic kidney disease continues to confer significant morbidity and mortality in the clinical setting. Despite high prevalence of these conditions, few validated biomarkers exist to predict kidney dysfunction. In this study, we ut
Externí odkaz:
https://doaj.org/article/e0badcdf9b7d4abe999b40d86cbb7ae5
Autor:
Maitray A. Patel, Michael J. Knauer, Michael Nicholson, Mark Daley, Logan R. Van Nynatten, Claudio Martin, Eric K. Patterson, Gediminas Cepinskas, Shannon L. Seney, Verena Dobretzberger, Markus Miholits, Brian Webb, Douglas D. Fraser
Publikováno v:
Molecular Medicine, Vol 28, Iss 1, Pp 1-12 (2022)
Abstract Background Long-COVID is characterized by prolonged, diffuse symptoms months after acute COVID-19. Accurate diagnosis and targeted therapies for Long-COVID are lacking. We investigated vascular transformation biomarkers in Long-COVID patient
Externí odkaz:
https://doaj.org/article/b84b3744940e4345b4f39f6d763bce27
Autor:
Douglas D. Fraser, Maitray A. Patel, Logan R. Van Nynatten, Claudio Martin, Shannon L. Seney, Michael R. Miller, Mark Daley, Marat Slessarev, Gediminas Cepinskas, Ganeem K. Juneja, Vanessa Sabourin, Alison Fox-Robichaud, Calvin H. Yeh, Paul Y. Kim, Sigrun Badrnya, Susanne Oehler, Markus Miholits, Brian Webb
Publikováno v:
Heliyon, Vol 9, Iss 1, Pp e12704- (2023)
Critically ill patients infected with SARS-CoV-2 display adaptive immunity, but it is unknown if they develop cross-reactivity to variants of concern (VOCs). We profiled cross-immunity against SARS-CoV-2 VOCs in naturally infected, non-vaccinated, cr
Externí odkaz:
https://doaj.org/article/17b7061f03df44f08da3ef0aeaeed36c
Autor:
Douglas D. Fraser, MD, PhD, Gediminas Cepinskas, DVM, PhD, Marat Slessarev, MD, MSc, Claudio M. Martin, MD, MSc, Mark Daley, PhD, Maitray A. Patel, BSc, Michael R. Miller, PhD, Eric K. Patterson, PhD, David B. O’Gorman, PhD, Sean E. Gill, PhD, Susanne Oehler, PhD, Markus Miholits, MSc, Brian Webb, PhD, on behalf of the Lawson COVID-19 Study Team, Robert Arntfield, Ian Ball, Gordon Barkwell, Tracey Bentall, Karen Bosma, Saoirse Cameron, Eileen Campbell, David Carter, Carolina Gillio-Meina, Robert Hegele, Natalya Odoardi, Ram Singh, Kelly Summers, Sue Tereschyn
Publikováno v:
Critical Care Explorations, Vol 3, Iss 3, p e0369 (2021)
Objectives:. Coronavirus disease 2019 continues to spread worldwide with high levels of morbidity and mortality. We performed anticoronavirus immunoglobulin G profiling of critically ill coronavirus disease 2019 patients to better define their underl
Externí odkaz:
https://doaj.org/article/b5452f32c170439fb320fdbdcd74f875
Autor:
Wegene Borena, Janine Kimpel, Melanie Gierer, Annika Rössler, Lydia Riepler, Susanne Oehler, Dorothee von Laer, Markus Miholits
Publikováno v:
Vaccines, Vol 9, Iss 6, p 611 (2021)
Serological assays that simultaneously detect antibodies to multiple targets of SARS-CoV-2 and to other structurally related coronaviruses provide a holistic picture of antibody response patterns. Well-validated multiplex immunoassays are scarce. Her
Externí odkaz:
https://doaj.org/article/af664e00ac8d47b8b206c4f9c32db426
Autor:
Douglas D. Fraser, Maitray A. Patel, Logan R. Van Nynatten, Claudio Martin, Shannon L. Seney, Michael R. Miller, Mark Daley, Marat Slessarev, Gediminas Cepinskas, Ganeem K. Juneja, Vanessa Sabourin, Alison Fox-Robichaud, Calvin H. Yeh, Paul Y. Kim, Sigrun Badrnya, Susanne Oehler, Markus Miholits, Brian Webb
Publikováno v:
Heliyon. 9(1)
Critically ill patients infected with SARS-CoV-2 display adaptive immunity, but it is unknown if they develop cross-reactivity to variants of concern (VOCs). We profiled cross-immunity against SARS-CoV-2 VOCs in naturally infected, non-vaccinated, cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4c10ab3de8365ae9a0ad8870de2f860
https://pubmed.ncbi.nlm.nih.gov/36594041
https://pubmed.ncbi.nlm.nih.gov/36594041
Autor:
Leticia A. Montoya, Shelley Das, Damon B. Cook, Markus Miholits, Brian C. McLucas, Thao H. Sebata, Chris M. Brotski
Publikováno v:
Methods. 158:27-32
Background The ability to simultaneously measure multiple secreted proteins and the corresponding gene expression levels from a single sample is valuable for comprehensive analysis. Bottlenecks to traditional immunoassays and gene expression assays i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed9e85927ccef8a97e789b9bee692c95
https://doi.org/10.1016/j.ymeth.2019.01.018
https://doi.org/10.1016/j.ymeth.2019.01.018
Autor:
Janine Kimpel, Annika Rössler, Wegene Borena, Susanne Oehler, Lydia Riepler, Markus Miholits, Melanie Gierer, Dorothee von Laer
Publikováno v:
Vaccines
Volume 9
Issue 6
Vaccines, Vol 9, Iss 611, p 611 (2021)
Volume 9
Issue 6
Vaccines, Vol 9, Iss 611, p 611 (2021)
Serological assays that simultaneously detect antibodies to multiple targets of SARS-CoV-2 and to other structurally related coronaviruses provide a holistic picture of antibody response patterns. Well-validated multiplex immunoassays are scarce. Her
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::437c63dc25aff429a12f0ef8daa4b66b
https://pubmed.ncbi.nlm.nih.gov/34200301
https://pubmed.ncbi.nlm.nih.gov/34200301